These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30806672)

  • 1. Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage?
    Bienek N; Maier C; Kaisler M; Michel-Lauter B; Schwarzer A; Meyer-Frießem CH
    Pain Med; 2019 Dec; 20(12):2438-2449. PubMed ID: 30806672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low pain intensity after opioid withdrawal as a first step of a comprehensive pain rehabilitation program predicts long-term nonuse of opioids in chronic noncancer pain.
    Krumova EK; Bennemann P; Kindler D; Schwarzer A; Zenz M; Maier C
    Clin J Pain; 2013 Sep; 29(9):760-9. PubMed ID: 23567163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opioid therapy for chronic noncancer pain: retrospective analysis of patients hospitalized for withdrawal].
    Faure D; Giniès P; Eiden C; Portet L; Peyrière H
    Therapie; 2013; 68(6):385-92. PubMed ID: 24356190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
    Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
    J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
    Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
    J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model.
    Monterubbianesi MC; Capuccini J; Ferioli I; Tassinari D; Sarti D; Raffaeli W
    J Opioid Manag; 2012; 8(5):292-8. PubMed ID: 23247906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program.
    Cunningham JL; Evans MM; King SM; Gehin JM; Loukianova LL
    Pain Med; 2016 Sep; 17(9):1676-85. PubMed ID: 26755658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and psychological factors associated with interdose opioid withdrawal in chronic pain population.
    Rodríguez-Espinosa S; Coloma-Carmona A; Pérez-Carbonell A; Román-Quiles JF; Carballo JL
    J Subst Abuse Treat; 2021 Oct; 129():108386. PubMed ID: 34080554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron does not prevent physical dependence in patients taking opioid medications chronically for pain control.
    Chu LF; Rico T; Cornell E; Obasi H; Encisco EM; Vertelney H; Gamble JG; Crawford CW; Sun J; Clemenson A; Erlendson MJ; Okada R; Carroll I; Clark JD
    Drug Alcohol Depend; 2018 Feb; 183():176-183. PubMed ID: 29278818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare presentation of intrathecal morphine withdrawal psychosis.
    Aiyer R; Jain V; Bhatia A; Mekinulov B; Gungor S
    Pain Manag; 2017 May; 7(3):171-173. PubMed ID: 28326948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weaning From Long-term Opioid Therapy.
    Moss C; Bossano C; Patel S; Powell A; Chan Seay R; Borahay MA
    Clin Obstet Gynecol; 2019 Mar; 62(1):98-109. PubMed ID: 30601171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.
    Jackson TP; Lonergan DF; Todd RD; Martin PR
    Pain Pract; 2013 Apr; 13(4):297-309. PubMed ID: 22925591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid tapering in hematopoietic progenitor cell transplant recipients.
    Pederson C; Parran L
    Oncol Nurs Forum; 2000 Oct; 27(9):1371-80. PubMed ID: 11058969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.
    Sullivan MD; Turner JA; DiLodovico C; D'Appollonio A; Stephens K; Chan YF
    J Pain; 2017 Mar; 18(3):308-318. PubMed ID: 27908840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE; Tompkins DA; Bigelow GE; Strain EC
    JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose lofexidine for medically directed outpatient opioid tapering in adults with chronic pain: a prospective case series.
    Ellis MM; Eberhart ND; Warner NS; Hooten WM
    J Med Case Rep; 2024 Jan; 18(1):20. PubMed ID: 38229200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of changes to daily dose of opioids on aspects of cognitive and psychomotor performance involved in driving].
    Gaertner J; Elsner F; Radbruch L; Kolibay F; Theisohn M; Berghaus G; Gerbershagen HJ; Dagtekin O; Sabatowski R
    Schmerz; 2008 Aug; 22(4):433-41. PubMed ID: 18219498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.